I'm of basically the same opinion, I'm expecting a dip post earnings. Even if the earnings exceed expectations, anyone who has been in CVSI long enough has seen that the recent trend the past few quarters is for the SP to suffer after earnings are reported. It's just the nature of being on OTC. That said I'm certainly not concerned about CVSI in the long run. I think its going to take FDA clarification, passage of the SAFE Banking Act, and uplisting to NASDAQ to get to the point where the SP is sanely reflected by earnings and potential, but in my opinion all of those are just a matter of time. Just be prepared to wait a bit longer.